New: Instantly spot drawdowns, dips, insider moves, and breakout themes across Maps and Screener.

Vivos Therapeutics, Inc

Contributing Author

Recent Articles by Vivos Therapeutics, Inc

Jan-20	Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds VVOS GlobeNewswire
Jan-16	Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds VVOS GlobeNewswire
Dec-16	Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan VVOS GlobeNewswire
Dec-15	Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST VVOS GlobeNewswire
Nov-19	Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025 VVOS GlobeNewswire
Nov-19	Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call VVOS GlobeNewswire
Sep-30	Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device VVOS GlobeNewswire
Sep-17	Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment VVOS GlobeNewswire
Aug-19	Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update VVOS GlobeNewswire
Aug-19	Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call VVOS GlobeNewswire
Jul-30	Vivos Therapeutics Adds to Management Team to Support Expansion and Growth VVOS GlobeNewswire
Jul-01	Vivos Therapeutics Receives Medicare Approval for VidaSleep Oral Appliance VVOS GlobeNewswire
Jun-26	New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children VVOS GlobeNewswire
Jun-11	Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada VVOS GlobeNewswire
May-15	Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update VVOS GlobeNewswire
May-14	Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call VVOS GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved.